Development and Psychometric Evaluation of the Antibiotic Knowledge and Consumption Tool (AKCT)

Knowledge of antibiotics and awareness of microbial resistance are essential for appropriate antibiotic consumption. This study aimed to develop and validate a measure of antibiotic knowledge and consumption (AKCT) and to make it available in the Arabic language and context. The tool was developed and applied on individuals ≥ 18 years, with mastery of Arabic or English. Exploratory factor analysis using principal-component analysis tested the psychometric properties of the items. AKCT scores were compared with the Infectious Numeracy Test (INT) scores to establish convergent validity. Cronbach’s α > 0.7 measured reliability. Three hundred-eighty-six participants completed the questionnaire, achieving a 95.3% response rate. Five components were retained after factor analysis: Side-effects and resistance, Access to antibiotics, Recovery after use, Antibiotics use indications, and Body response. Cronbach’s α = 0.85. The mean ± SD of AKCT = 9.82 ± 3.85 (range = 7−20); lowest scores were related to “Side-effects and resistance” (2.32 ± 2.00, max = 7) and “Antibiotic use indications” (1.61 ± 1.29, max = 5). Scores on the AKCT and INT positively correlated. The AKCT is a valuable, valid, and reliable tool developed for measurement of antibiotic knowledge and consumption behaviors to identify specific areas needing improvements; hence, targeted interventions are devised.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Antibiotics (Basel, Switzerland) - 11(2022), 12 vom: 02. Dez.

Sprache:

Englisch

Beteiligte Personen:

Hasan, Sanah [VerfasserIn]
Sulieman, Hana [VerfasserIn]
Babi, Husam [VerfasserIn]
Bloukh, Samir [VerfasserIn]

Links:

Volltext

Themen:

Antibiotic knowledge
Arabic
Journal Article
Tool development
Translation and cultural adaptation
United Arab Emirates

Anmerkungen:

Date Revised 08.03.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/antibiotics11121744

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM350629234